|
Mar 5
|
Why Dialysis Stocks Are up Today
|
|
Mar 5
|
Fresenius Medical Care Achieves Next Milestone in Portfolio Optimization Program, Announcing Sale of Dialysis Clinics in Brazil, Colombia, Chile, Ecuador
|
|
Mar 5
|
Dialysis providers gain as investors focus on cardiac benefits after Ozempic's latest data
|
|
Jan 12
|
Medical logistics company divesting trucking, cross-dock operations
|
|
Jan 9
|
Fresenius Medical (FMS) Divests Businesses to Optimize Portfolio
|
|
Dec 20
|
Reasons to Retain Fresenius Medical (FMS) in Your Portfolio Now
|
|
Dec 6
|
Fresenius Medical Care says data on 500,000 people stolen in U.S
|
|
Nov 30
|
Fresenius Medical Care completes change of legal form into a German stock corporation
|
|
Nov 8
|
Fresenius sells fertility business to KKR and GED Capital
|
|
Nov 7
|
At €32.00, Is Fresenius Medical Care AG & Co. KGaA (ETR:FME) Worth Looking At Closely?
|
|
Nov 3
|
Fresenius Medical (FMS) Q3 Earnings Miss, Operating Margin Up
|
|
Nov 3
|
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q3 2023 Earnings Call Transcript
|
|
Nov 2
|
UPDATE 1-Dialysis firm FMC sees 'balanced' impact from GLP-1 drugs on its patients
|
|
Sep 6
|
Are Options Traders Betting on a Big Move in Fresenius Medical Care (FMS) Stock?
|
|
May 4
|
Fresenius Medical Care AG & Co. KGaA (ETR:FME) is a favorite amongst institutional investors who own 44%
|